- Home
- J&J Innovative Medicine
J&J Innovative Medicine
This researcher made good on his high school promise to improve how we treat depression
As a teenager, Wayne Drevets, M.D., had friends who struggled with depression—and who ultimately inspired him to focus his career on helping people with the debilitating disorder.
Battling the baby blues: Meet 3 researchers whose innovative work is all about boosting the mental health of moms
A staggering 1 in 7 women suffer from perinatal mood disorders, which can begin as early as pregnancy. We take a look at how these scientists are working to find ways to help halt depression in moms at the most critical juncture: before it starts.
New study shows researchers may be one step closer to intercepting lung cancer earlier
A team of scientists, including those from Janssen and the Lung Cancer Initiative at Johnson & Johnson, found that biomarkers related to the immune system may be able to aid doctors in identifying high-risk lung cancer patients—and treating them—at the earliest stage of the disease.
3 innovative ways one company is helping rethink how we treat mental healthcare
From scientists in research labs to CEOs at companies across the country, here’s how one healthcare company is partnering with people from all walks of life to help drive change in how we treat mental disorders—and the stigma often associated with them.
A vaccine for E. coli? Meet a researcher hot on the trail
A particular strain of the bacteria can be deadly for those over the age of 60—and it’s not the kind that causes food poisoning. But this Janssen researcher is committed to finding a preventive treatment.
What you need to know about Johnson & Johnson’s 2019 first-quarter earnings
Check out this infographic breakdown of the company’s first-quarter 2019 performance, with key highlights from its consumer, pharmaceutical and medical devices businesses.
From Aha! moment to FDA approval: The fascinating story behind a new treatment for bladder cancer
For National Cancer Prevention Month, we retrace the 22-year journey it took to bring a potentially life-changing treatment for an aggressive form of bladder cancer to patients who may benefit most.
“I had four strokes and two brain surgeries—and survived”
Lisa Deck was just 21 when she had her first stroke. She would go on to have three more, as well as face a rare diagnosis of moyamoya disease. For World Stroke Day, we’re sharing her incredible story of survival and living with a chronic illness.
How Johnson & Johnson is helping tackle a devastating tropical disease that impacts kids
A new World Health Organization prequalification for mebendazole means the company can reach even more young people with intestinal worm infections around the globe.
5 things to know about the 2018 Janssen U.S. Transparency Report
The company just released its third annual report and leaders from across Janssen share some top takeaways, including a new initiative to include the list price and potential out-of-pocket costs for its most frequently prescribed medicine.